Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18”

109 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 109 results

Testing effectiveness (Phase 2)Study completedNCT00411749
What this trial is testing

V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)

Who this might be right for
HPV Infections
Merck Sharp & Dohme LLC 107
Testing effectiveness (Phase 2)Study completedNCT01461993
What this trial is testing

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Who this might be right for
VaccinesMeningococcal Vaccines
Pfizer 2,499
Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Post-approval studies (Phase 4)Active Not RecruitingNCT03943875
What this trial is testing

GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose

Who this might be right for
ImmunizationEfficacyHuman Papilloma Virus
The University of Texas Medical Branch, Galveston 767
Large-scale testing (Phase 3)Study completedNCT01304498
What this trial is testing

Immunogenicity and Tolerability of V503 Versus GARDASIL (V503-009)

Who this might be right for
Human Papillomavirus
Merck Sharp & Dohme LLC 600
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07339163
What this trial is testing

Efficacy of Booster Injection With Gardasil-9 Vaccine on Intersurgical Interval* for Adults With Recurrent Respiratory Papillomatosis*

Who this might be right for
Recurrent Respiratory Papillomatosis (RRP)
Ohio State University 50
Large-scale testing (Phase 3)Study completedNCT03546842
What this trial is testing

Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017)

Who this might be right for
Papillomavirus InfectionsUterine Cervical NeoplasmsVulvar Neoplasms+3 more
Merck Sharp & Dohme LLC 201
Large-scale testing (Phase 3)UnknownNCT05668572
What this trial is testing

A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 12,000
Early research (Phase 1)Study completedNCT00851643
What this trial is testing

Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002)

Who this might be right for
Human Papilloma VirusCervical CancerVulvar Cancer+2 more
Merck Sharp & Dohme LLC 158
Large-scale testing (Phase 3)Study completedNCT03728881
What this trial is testing

Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial

Who this might be right for
Human Papillomavirus-Related Cervical Carcinoma
National Cancer Institute (NCI) 1,240
Post-approval studies (Phase 4)Study completedNCT01914367
What this trial is testing

Study of the Molecular Mechanisms Underlying the Cross-neutralizing Capacity of AS04-adjuvanted HPV Vaccine (Cervarix®) in Comparison With the Aluminiumhydroxyphosphate Sulphate Adjuvanted HPV Vaccine (Gardasil®)

Who this might be right for
Infection With Human Papillomavirus
University Hospital, Ghent 12
Large-scale testing (Phase 3)Study completedNCT04782895
What this trial is testing

Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 488
Large-scale testing (Phase 3)Study completedNCT00813319
What this trial is testing

Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females

Who this might be right for
Vaccination
Emory University 216
Large-scale testing (Phase 3)WithdrawnNCT00733122
What this trial is testing

Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034)

Who this might be right for
HPV Infections
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT00524745
What this trial is testing

Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil

Who this might be right for
Dose Schedule Study
PATH 903
Large-scale testing (Phase 3)Study completedNCT00423046
What this trial is testing

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 1,106
Large-scale testing (Phase 3)Study completedNCT01862874
What this trial is testing

Efficacy and Tolerability Study of V501 in Japanese Males (V501-122)

Who this might be right for
Anogenital Human Papilloma Virus InfectionCondyloma Acuminata
Merck Sharp & Dohme LLC 1,124
Post-approval studies (Phase 4)Active Not RecruitingNCT05557370
What this trial is testing

Immunogenicity of HPV Vaccine in Transplant Recipients.

Who this might be right for
Chronic Kidney DiseasesKidney Transplant
Medical College of Wisconsin 30
Early research (Phase 1)Ended earlyNCT00798265
What this trial is testing

A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults

Who this might be right for
Human Immunodeficiency VirusHuman Papillomavirus- 6, 11, 16, 18Adolescent+1 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03947775
What this trial is testing

HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL

Who this might be right for
Anal Intraepithelial NeoplasiaAnal CancerHuman Papilloma Virus
University Health Network, Toronto 228
Load More Results